DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | AliX | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | BioMedical Diagnostics | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-modeling) | BT Pharma | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | Cezanne | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Exonhit | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences (AbAg) | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | Magnisense | Mapreg | MAT Biopharma | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | Novagali | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma (ex-Nova Decision) | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharmaxon | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sepal Pharma | Serial Genetics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UroGene | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |

* UROGENE *


 

1998 - IDF
Paris
www.urogene.com

 

Discovery, Drugs
(also, Development, Drugs)
Key words: Urinary tract dysfunctions, Prostate, Bladder Cancer
Mission: to develop innovative drugs in urology
Clients: Pharmaceutical companies (own development up to phase III)
info@urogene.com

Age: 14 year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Start-up |
Managing Dir.-CEO: Attali (Pierre) [born 1950, M.D., M.Sc., ex-Cerep, Molecular Engines Labs, Synthélabo]
Sc.Dir.-CSO: Bienaymé (Hugues) [born 1963, Ph.D. organic chemistry, ex-Chrysalon, Rhône-Poulenc Rorer]
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): Société Générale A.M., Capricorn Venture Partners, Nuage, FCJE (CDC), Genavent, OSEO-ANVAR

Turnover (M€) : n.a.
Total funding (M€) : 15.0
Last funding (M€) : 1.5
Focus : Cancers
Position : Clinical
Company confirm : none

 

History
DATEMILESTONETYPETIME
2008 .08 No website news update since November 2006 (net capital : - 3 M€ in December 2006, but legal capital increases in September 2007, August 2008, August 2009, February 2010) INFO [10 years]
2006 .01 Seed financing : 1.5 M€, by historical investors SFIN [7 years]
2005 .01 Divestiture of drug discovery platform (including Chrysalon) to Pierre Fabre ACQ- [6 years]
2004 .01 Licensing-in of Besipirdine exclusive rights from Aventis LICIN [5 years]
2003 .03 2nd round-financing : 12.0 M€, led by Société Générale Asset Management (SGAM) RFINB [5 years]
2002 .07 Acquisition of Chrysalon, a chemical company, spin-off from Aventis ACQ+ [4 years]
2000 .12 Nomination : Christian Grenier [born 1950, Sup de Co Paris, MBA, ex-Rhône Poulenc], as CEO ORGN [2 years]
2000 .09 1st round-financing : 2.0 M€, by Société Générale A.M., business angels RFINA [2 years]
1998 .04 Seed financing : 1.5 M€, by founders and public funding SFIN [0 year]
1998 .03 Company founded by Dr Philippe Berthon [CEO, Ph.D. cancerology], Dr Olivier Cussenot [CSO, Ph.D., M.D. surgery, Prof. urology], with Pierre Teillac [born 1960] and others ORGF [0 year]

Actualisation / Updating: 9-May-2011

   


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2011. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende